TrialClinical pharmacokinetics2019

Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model-Support for a Biologics License Application Submission: Part I.

Jean-Marie Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.